LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 52 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $675,106 | +89.2% | 121,422 | +149.8% | 0.00% | – |
| Q2 2023 | $356,805 | +141.4% | 48,611 | +29.2% | 0.00% | – |
| Q1 2023 | $147,811 | +24.4% | 37,611 | 0.0% | 0.00% | – |
| Q4 2022 | $118,851 | -12.0% | 37,611 | 0.0% | 0.00% | – |
| Q3 2022 | $135,000 | +16.4% | 37,611 | 0.0% | 0.00% | – |
| Q2 2022 | $116,000 | -40.5% | 37,611 | -0.0% | 0.00% | – |
| Q1 2022 | $195,000 | -20.7% | 37,624 | -26.0% | 0.00% | – |
| Q4 2021 | $246,000 | -51.8% | 50,850 | -11.2% | 0.00% | -100.0% |
| Q3 2021 | $510,000 | +233.3% | 57,275 | +237.1% | 0.00% | – |
| Q2 2021 | $153,000 | -44.8% | 16,993 | 0.0% | 0.00% | – |
| Q1 2021 | $277,000 | – | 16,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |